Yet again I've been sucked into the Technegas FDA hype and yet again I've been burned. For the uninitiated (and delusional, posting optimistically here) Cyclopharm have been seeking FDA approval for thirty years! THIRTY YEARS! Ian Tetley first gave it a shot before he back-doored his company onto the ASX and sold out. I've previously posted my suspicion that the inferior aerosol competitor in the US must be exerting political pressure to stymie Cyclopharm's FDA process. With Technegas patents lapsing this decade, Cyclopharm will be lucky to have any first to market advantage. That said I really thought it would happen this time, with Covid et al. Will investors be further diluted in the next twelve months? Track record says yes. Will Cyclopharm be my biggest loss of all time? - it already is. Will I buy again in 2022? - most probably.
CYC Price at posting:
$1.76 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)